Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Can Respir J ; 2021: 8899878, 2021.
Article in English | MEDLINE | ID: mdl-34336047

ABSTRACT

Abnormal proliferation of airway smooth muscle cells (ASMCs) leads to airway remodeling and the development of asthma. This study aimed to assess whether mitochondrial ATP-sensitive K+ (mitoKATP) channels regulated the proliferation of ASMCs by regulating the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway in asthmatic rats. Forty-eight Sprague Dawley rats were immunized with ovalbumin-containing alum to establish the asthma models. The ASMCs were isolated and identified by phase-contrast microscopic images and immunohistochemical staining for α-smooth muscle actin. The ASMCs were treated with a potent activator of mitoKATP, diazoxide, or an inhibitor of mitoKATP, 5-hydroxydecanoate (5-HD). Rhodamine-123 (R-123) was used for detecting the mitochondrial membrane potential (Δψm). The proliferation of ASMCs was examined by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay. The protein and mRNA expressions of AKT and p-AKT were detected using western blotting and quantitative real-time PCR. The results showed that diazoxide enhanced the mitoKATP channel opening in ASMCs in the rat model of asthma, while 5-HD impeded it. Diazoxide also increased ASMC proliferation in the rat model of asthma, whereas 5-HD alleviated it. However, LY294002, a PI3K/AKT pathway inhibitor, reversed the functional roles of diazoxide in the proliferation ability of ASMCs in the rat model of asthma. Furthermore, treatment with diazoxide induced the phosphorylation of AKT, and treatment with 5-HD decreased the phosphorylation of AKT in ASMCs in the rat model of asthma. In conclusion, the mitoKATP channel opening increased the proliferation of ASMCs by activating the PI3K/AKT signaling pathway in a rat model of asthma.


Subject(s)
Asthma , Proto-Oncogene Proteins c-akt , Adenosine Triphosphate , Animals , Asthma/drug therapy , Cell Proliferation , Cells, Cultured , Myocytes, Smooth Muscle , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Sprague-Dawley , Signal Transduction
2.
Neural Netw ; 143: 1-11, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34051525

ABSTRACT

Zero-shot learning (ZSL) aims to recognize objects in images when no training data is available for the object classes. Under generalized zero-shot learning (GZSL) setting, the test objects belong to seen or unseen categories. In many recent studies, zero-shot learning is performed by leveraging generative networks to synthesize visual features for unseen class from class-specific semantic features. The user-defined semantic information is incomplete and lack of discriminability. However, most generative methods use user-defined semantic information directly as constraints of the generative model, which makes the visual features synthesized by the models lack of diversity and separability. In this paper, we propose a novel method to improve the semantic feature by utilizing discriminative visual features. Furthermore, a novel Augmented Semantic Feature Based Generative Network (ASFGN) is built to synthesize the separable visual representations for unseen classes. Since GAN-based generative model may suffer from mode collapse, we propose a novel collapse-alleviate loss to improve the training stability and generalization performance of our generative network. Extensive experiments on four benchmark datasets prove that our method outperforms the state-of-art approaches in both ZSL and GZSL settings.


Subject(s)
Machine Learning , Semantics , Learning
3.
PLoS One ; 11(9): e0162393, 2016.
Article in English | MEDLINE | ID: mdl-27617447

ABSTRACT

BACKGROUND: Interleukin-25 (IL-25) is a potent activator of type-2 immune responses, and is responsible for airway inflammation in asthma. Previous reports have shown that IL-25 expressed hyper-reactivity in an experimental mouse-model of asthma. In addition, the production of IL-13/IL-5 promoted by nuocytes induced airway inflammation. Thus, it has been questioned whether blocking IL-25 against its receptor IL-17BR could inhibit the expression of IL-13 and IL-5 via nuocytes, and further protect against inflammation in ovalbumin (OVA) induced mouse-model of asthma. METHODS: In this study, in order to investigate the correlation among IL-25, IL-5, IL-13 and nuocyte activities, we used OVA-sensitization and -challenging to induce the mouse model of asthma. The murine asthmatic model was validated by histology. The expressions of IL-5, IL-13 and IL-25 were detected by ELISA, quantitative real-time PCR, and western blotting of the lung tissue. Nuocyte activation was identified by the levels of ICOS (clone C398.4A) and T1/ST2 (cloneDJ8) (acting as nuocytes surface markers) in the bronchoalveolar lavage fluid (BALF). This, in turn, was done by means of flow cytometry. The expressions of IL-25, IL-5 and IL-13 in our murine model were detected in the BALF. RESULTS: The mice sensitized and challenged with OVA showed a high expression of IL-25 in both the mRNA and protein levels in lungs. The expressions of ICOS and T1/ST2 in BALF were increased. A significant correlation between IL-25 mRNA, protein, and other Th2-cell producing cytokines (such as IL-5 and IL-13) moreover were identified. Furthermore, when the asthmatic mice were treated with anti-IL-25, both the inflammatory cells' infiltration and the inflammatory cytokines' secretion were significantly decreased. The present findings indicate that IL-25 might be involved in a series of asthmatic immune responses, playing an important role in the increase of nuocytes, and that its activation is necessary in maintaining Th2 central memory and sustaining asthmatic inflammation. CONCLUSION: This study showed that IL-25 promoted the accumulation of ICOS and T1/ST2 on nuocytes, further induced the pro-inflammatory Th2 cells, and promoted Th2 cytokine responses in OVA-induced airway inflammation.


Subject(s)
Asthma/immunology , Disease Models, Animal , Interleukin-17/physiology , Th2 Cells/immunology , Animals , Bronchoalveolar Lavage Fluid , Female , Inflammation/pathology , Inflammation Mediators/physiology , Interleukin-17/metabolism , Mice , Mice, Inbred BALB C , Ovalbumin/administration & dosage
4.
Oncol Lett ; 11(5): 3135-3138, 2016 May.
Article in English | MEDLINE | ID: mdl-27123077

ABSTRACT

Gastrointestinal stromal tumors (GISTs) are the most common type of mesenchymal tumor of the gastrointestinal tract. The stomach and small intestine are the most common sites of occurrence. GISTs are mesenchymal neoplasms originating from the interstitial cells of Cajal (ICCs), and are characterized by positivity for cluster of differentiation (CD) 117, also known as proto-oncogene c-Kit. While the majority of GISTs develop in the alimentary tract, in rare cases they may also be found in extragastrointestinal tissues. This type of GIST is known as an extragastrointestinal stromal tumor (EGIST). Despite the fact that EGISTs have been reported in the mesentery, omentum and retroperitoneum, primary intrathoracic EGISTs, arising from the pleura or lungs, are rare. The patient presented in the current study was a 40-year-old man, who presented with a cough and pyrexia, with pleural effusion on the left side. Multiple nodules throughout the parietal pleura were identified by thoracoscopy and a diagnosis of primary GIST of pleura was established, since they were positive for CD117 and discovered on GIST-1 and there was no evidence of gastrointestinal tumors. Subsequently, the patient was administered with imatinib and had no signs of disease recurrence 2 years later.

5.
Mol Med Rep ; 13(1): 373-8, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26549479

ABSTRACT

Catalpol, an iridiod glucoside isolated from Rehmannia glutinosa, has been reported to possess anti­inflammatory properties. However, the molecular mechanisms underlying this effect have not been fully elucidated. This study aimed to investigate the effects of catalpol on vascular permeability. Using Transwell permeability assays and measurements of trans­endothelial electrical resistance (TEER), it was demonstrated that 1 mM catalpol induces a significant increase in the permeability of the monolayers of human umbilical vein endothelial cells (HUVECs). Western blotting and immunofluorescence demonstrated that catalpol inhibits the expression of vascular endothelial (VE)­cadherin, the key component of adherens junctions, but not occludin, the major constituent of tight junctions. In addition, catalpol inhibits the ETS transcription factor ERG, a positive regulator of VE­cadherin. Knockdown of ERG expression compromised the catalpol­induced reduction of TEER in HUVECs. The present study revealed a novel effect of catalpol on vascular permeability and gave insight into the multifaceted roles of catalpol in inflammation.


Subject(s)
Antigens, CD/metabolism , Cadherins/metabolism , Capillary Permeability/drug effects , Down-Regulation/drug effects , Endothelium, Vascular/metabolism , Iridoid Glucosides/pharmacology , Dose-Response Relationship, Drug , Endothelium, Vascular/drug effects , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Occludin/metabolism , Protein Transport/drug effects , Trans-Activators/metabolism , Transcriptional Regulator ERG
SELECTION OF CITATIONS
SEARCH DETAIL
...